Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HTR3A | P46098 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21367140 | 0.85 | MAOA (0.54) | TAAR1CYP2A6CYP1A2ESR1HTR2A | |
| SCHEMBL10875275 | 0.84 | HTR2A (0.59) | TAAR1CYP2A6CYP1A2HTR2AKDM4E | |
| SCHEMBL861221 | 0.82 | ESR1 (0.61) | TAAR1ESR1HTR2AALDH1A1SLC6A2 | |
| SCHEMBL6685103 | 0.82 | ESR1 (0.74) | TAAR1ESR1HTR2AALDH1A1SLC6A2 | |
| SCHEMBL74590 | 0.80 | ESR1 (0.58) | TAAR1ESR1HTR2ASLC6A2LOXL2 | |
| SCHEMBL224548 | 0.79 | TAAR1 (0.72) | TAAR1CYP2A6CYP1A2HTR2AKDM4E | |
| SCHEMBL22386740 | 0.79 | TAAR1 (0.57) | TAAR1CYP2A6HTR2AKDM4ELOXL2 | |
| Ethane SCHEMBL23291175 | 0.77 | GFER (0.68) | TAAR1CYP2A6CYP1A2HTR2AKDM4E | |
| SCHEMBL143553 | 0.76 | GFER (0.77) | TAAR1CYP2A6CYP1A2HTR2AKDM4E | |
| SCHEMBL716077 | 0.76 | TAAR1 (0.61) | TAAR1CYP2A6CYP1A2HTR2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210159135-A1 | CROSS LINKED SURFACE COATING AND INTERFACIAL LAYER FOR A PEROVSKITE MATERIAL PHOTOVOLTAIC DEVICE | CUBICPV INC. | 2021-05-27 | — | — | US | disclosed |
| US-20210159419-A1 | NON-FULLERENE ACCEPTORS (NFAS) AS INTERFACIAL LAYERS IN PEROVSKITE SEMICONDUCTOR DEVICES | CUBICPV INC. | 2021-05-27 | — | — | US | disclosed |
| WO-2020060494-A1 | ACID-SENSITIVE DEGRADABLE IMIDAZOLIUM POLYMERS FOR ANTIMICROBIAL APPLICATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-03-26 | — | — | WO | disclosed |
| EP-2427451-B1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM BIOLAB CO LTD (JP) | 2019-03-20 | — | — | EP | disclosed |
| WO-2018026743-A1 | CROSSLINKING OF HYDROXIDE STABLE, POLYBENZIMIDAZOLIUMS AND POLYIMIDAZOLIUMS MEMBRANES AND IONOMERS | SIMON FRASER UNIVERSITY (CA) | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210159419-A1 | NON-FULLERENE ACCEPTORS (NFAS) AS INTERFACIAL LAYERS IN PEROVSKITE SEMICONDUCTOR DEVICES | NBAS, TNK1, NME1 | TAAR1 1535/4885CYP2A6 2910/4885CYP1A2 1057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.